Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-025496

Director sold 5,000 shares at $15.06 ($75,300)

  • Director acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ABERCROMBIE GEORGE B · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-15 Exercise or conversion : show line 1 in the form +5,000 $2.63 $13,150 5,000 D
2021-09-15 Sale : show line 2 in the form −5,000 $15.06 $75,300 0 D
Open-market sales · 5,000 sh · avg $15.06 · $75,300

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-15 Exercise or conversion : show line 3 in the form Non-Qualified Stock Option −5,000 0 D
Loading xslF345X03/form4.xml…